| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 87 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 87 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 87 |
| 3 | ETOPOSIDE | 75 |
| 4 | DINUTUXIMAB | 56 |
| 5 | CARBOPLATIN | 42 |
| 6 | TOPOTECAN | 40 |
| 7 | DOXORUBICIN | 39 |
| 8 | CISPLATIN | 35 |
| 9 | TEMOZOLOMIDE | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFLORNITHINE HYDROCHLORIDE | 4 | 0.0952 |
| 1 | NIFURTIMOX | 2 | 0.0769 |
| 2 | DINUTUXIMAB | 56 | 0.0652 |
| 3 | DEXAMETHASONE INTENSOL | 1 | 0.0278 |
| 4 | NAXITAMAB | 6 | 0.0240 |
| 5 | SODIUM CITRATE AND CITRIC ACID | 1 | 0.0208 |
| 6 | INTERLEUKIN-10 | 6 | 0.0167 |
| 7 | IOBENGUANE I-123 | 1 | 0.0088 |
| 8 | ALDESLEUKIN | 10 | 0.0079 |
| 9 | TOPOTECAN | 40 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 121 |
| 1 | Topoisomerase Inhibitor [EPC] | 92 |
| 2 | Platinum-based Drug [EPC] | 61 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 58 |
| 4 | Opioid Agonist [EPC] | 32 |
| 5 | Kinase Inhibitor [EPC] | 28 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 7 | Retinoid [EPC] | 27 |
| 8 | Leukocyte Growth Factor [EPC] | 25 |
| 9 | Corticosteroid [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 58 | 0.0535 |
| 1 | Lymphocyte Growth Factor [EPC] | 10 | 0.0079 |
| 2 | Nitrogen Binding Agent [EPC] | 5 | 0.0021 |
| 3 | Actinomycin [EPC] | 3 | 0.0014 |
| 4 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 5 | Topoisomerase Inhibitor [EPC] | 92 | 0.0012 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 7 | Alkylating Drug [EPC] | 121 | 0.0005 |
| 8 | Gonadotropin [EPC] | 1 | 0.0005 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 2 | 0.0004 |